Novacyt H1 Loss Narrows As Revenue Rises 18%
(RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services, reported higher revenue and a narrower loss for the six months ended June 30, 2026.
В этом разделе статьи показаны на английском.
Novacyt H1 Loss Narrows As Revenue Rises 18%
Сводка Trade News от 2026-10-01: Novacyt H1 Loss Narrows As Revenue Rises 18% (RTTNews) - Novacyt S.A. (NCYT.L), a diagnostics company providing molecular testing technologies and services,… Первоисточник — оригинал Nasdaq Market Structure (nasdaq.com).